微创经椎间孔腰椎椎间融合术与内镜下经椎间孔腰椎椎间融合术治疗腰椎退行性疾病的结果比较:一项回顾性匹配病例对照研究
本研究回顾性分析2016年6月至2019年6月在本院接受单节段Mis-TLIF或Endo-TLIF的患者,按性别、年龄和腰椎退行性疾病类型1:1匹配,比较出院时及术后1年、2年的临床结果。共纳入64例,每组32例。Endo-TLIF组手术时间和透视时间显著更长,而估计失血量、术后引流量和出院时腰痛视觉模拟评分显著更低。两组最终随访均达到确切椎间融合,术后1年和2年视觉模拟评分及Oswestry功能障碍指数无显著差异。Endo-TLIF组并发症发生率(21.9%)高于Mis-TLIF组(6.2%),但差异无统计学意义。
要点
- Endo-TLIF组手术时间和透视时间显著长于Mis-TLIF组。
- Endo-TLIF组估计失血量、术后引流量和出院时腰痛VAS评分显著低于Mis-TLIF组。
- 两组术后1年和2年VAS评分及ODI无显著差异,并发症率差异无统计学意义。
核心结论
- 两种治疗长期结果无差异,但Endo-TLIF失血更少、术后引流量更低、出院时腰痛VAS评分更低;Endo-TLIF手术时间更长且并发症率可能更高,提示外科医生可能需要克服比Mis-TLIF更陡的学习曲线。
研究设计与样本
- 回顾性匹配病例对照研究,纳入2016年6月至2019年6月在本院接受单节段Mis-TLIF或Endo-TLIF的患者,按性别、年龄和腰椎退行性疾病类型1:1匹配,共64例,每组32例。
主要发现
- Endo-TLIF组手术时间和透视时间显著高于Mis-TLIF组。
- Endo-TLIF组估计失血量、术后引流量和出院时腰痛视觉模拟评分显著低于Mis-TLIF组。
- 两组最终随访均达到确切椎间融合。
- 两组术后1年和2年视觉模拟评分及Oswestry功能障碍指数无显著差异。
- Endo-TLIF组并发症发生率(21.9%)高于Mis-TLIF组(6.2%),但差异无统计学意义。
关键数值与推荐
- Endo-TLIF组并发症发生率为21.9%,Mis-TLIF组为6.2%,差异无统计学意义。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We compared the clinical outcomes of minimally invasive transforaminal lumbar interbody fusion (Mis-TLIF) and endoscopic transforaminal lumbar interbody fusion (Endo-TLIF). METHODS: We retrospectively analyzed the clinical data of patients who underwent single-segment Mis-TLIF or Endo-TLIF between June 2016 and June 2019 at our hospital. The patients in each treatment group were matched 1:1 for sex, age, and type of lumbar degenerative disease, and their clinical outcomes were compared at discharge and at 1 and 2 years postoperatively. RESULTS: Our study included 64 patients, with 32 patients in each treatment group. Operative time and fluoroscopy time were significantly higher in the Endo-TLIF versus Mis-TLIF groups, whereas estimated blood loss, postoperative drainage volume, and the low back pain visual analog scale score at discharge were significantly lower. Both treatments achieved exact interbody fusion at the final-follow up. There was no significant difference in the visual analog scale score or Oswestry Disability Index between the groups at 1 and 2 years postoperatively. Complication rates were higher in the Endo-TLIF group (21.9%) than in the Mis-TLIF group (6.2%), although the difference was not significant. CONCLUSIONS: Although there was no difference in the long-term outcomes between the treatments, Endo-TLIF had less blood loss and a lower postoperative drainage volume and low back pain visual analog scale score at discharge than Mis-TLIF. However, the longer operative time and potentially higher complication rate of Endo-TLIF suggest that surgeons may need to overcome the steeper learning curve than the procedure of Mis-TLIF.
引用
- Shi L, Ding T, Shi Y, et al. Comparison of the Outcomes of Minimally Invasive Transforaminal Lumbar Interbody Fusion and Endoscopic Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Diseases: A Retrospective Matched Case-Control Study. World Neurosurg. 2022. PMID: 36096389. doi:10.1016/j.wneu.2022.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。